This Article Full Text Full Text (PDF) All Versions of this Article: 35/7/1589    most recent 01.STR.0000132194.24663.3dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slowik, A. Articles by Szczudlik, A. Search for Related Content PubMed PubMed Citation Articles by Slowik, A. Articles by Szczudlik, A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Stroke Related Collections Carotid Stenosis Genetics of Stroke Platelets

(Stroke. 2004;35:1589.)
© 2004 American Heart Association, Inc.

Original Contributions

A2 Alelle of GpIIIa Gene Is a Risk Factor for Stroke Caused by Large-Vessel Disease in Males

Agnieszka Slowik, MD; Tomasz Dziedzic, MD; Wojciech Turaj, MD; Joanna Pera, MD; Lidia Glodzik-Sobanska, MD; Pawel Szermer, MD; Maciej T. Malecki, MD; Denise A. Figlewicz, PhD Andrzej Szczudlik, MD, PhD

From the Department of Neurology (A.S., T.D., W.T., J.P., L.G.-S., P.S., A.S.) and the Department of Metabolic Diseases (M.T.M.), Jagiellonian University, Krakow, Poland; and the Department of Neurology (D.A.F.), University of Michigan, Ann Arbor, Mich.

Correspondence to Dr Agnieszka Slowik, Department of Neurology, Jagiellonian University, 31-503 Krakow, Botaniczna 3, Poland. E-mail slowik{at}neuro.cm-uj.krakow.pl

Background and Purpose— Glycoprotein IIIa (GpIIIa) is a platelet membrane receptor for fibrinogen and von Willebrand factor. It plays a key role in platelet aggregation. Previous studies in stroke patients, without analysis based on specific subtypes of stroke cause, have not shown any link between GpIIIa A1/A2 polymorphism and stroke risk. We studied the significance of the GpIIIa gene A1/A2 polymorphism in stroke patients with different stroke causes.

Methods— We genotyped 92 patients with stroke caused by large-vessel disease (LVD stroke) and 184 matched controls; 103 patients with stroke caused by small-vessel disease (SVD stroke) and 206 controls; and 182 patients with cardioembolic stroke (CE stroke) and 182 controls (TOAST criteria). The GpIIIa A1/A2 polymorphism was analyzed by polymerase chain reaction followed by restriction enzyme digestion and electrophoresis.

Results— The genotype distribution of the GpIIIa gene in patients with LVD stroke (A1/A1, 63%; A1/A2, 34.8%; A2/A2, 2.2%) differed significantly from their controls (A1A1, 79.3%; A1/A2, 20.1%; A2/A2, 0.6%). The distribution of the GpIIIa A1/A2 polymorphism in patients with SVD stroke and CE stroke was similar to that of their controls. In contrast to females with LVD stroke, we found that males with LVD stroke presented with an overrepresentation of at least 1 A2 allele of the GpIIIa gene when compared with their controls (39.7% versus 23.0%; P=0.003). Conditional logistic regression analysis showed that possession of at least 1 A2 allele of the GpIIIa gene was an independent risk factor for LVD stroke in males (OR, 2.51; 95% CI, 1.21 to 5.20).

Conclusion— A2 allele of the GpIIIa gene is an independent risk factor for LVD stroke in males.

Key Words: etiology • stroke • platelet glycoprotein GPIIb/IIIa complex • gene expression • polymorphism

This article has been cited by other articles:

				M. J. Alberts and E. Tournier-Lasserve Update on the Genetics of Stroke and Cerebrovascular Disease 2004 Stroke, February 1, 2005; 36(2): 179 - 181. [Full Text] [PDF]